Authors: Andreu S, Ripa I, Bello-Morales R, Lopez-Guerrero JA PMID: 33256172 PMCID: PMC7760627 DOI: 10.3390/v12121356 Abstract Herpes simplex viruses (HSVs) are neurotropic viruses with broad host range whose infections cause considerable health problems in both animals and humans. In fact, 67% of the global population under the age of 50 are infected with HSV-1 and [...]

Authors: Le Balc'h P, Pinceaux K, Pronier C, Seguin P, Reizine F PMID: 32859241 PMCID: PMC7453668 DOI: 10.1186/s13054-020-03252-3 Abstract The SARS-CoV-2 infection can lead to severe acute respiratory distress syndrome (ARDS) with prolonged mechanical ventilation (MV). Patients with coronavirus disease 2019 (COVID-19) associated ARDS usually met the diagnosis criteria for sepsis-associated immunosuppression as acquired infections, [...]

Authors: Griffith RS, Norins AL, Kagan C PMID: 640102 DOI: 10.1159/000250926 Abstract Lysine appears to suppress the clinical manifestations of herpesvirus infection. 45 patients with frequently recurring herpes infection were given 312-1,200 mg of lysine daily in single or multiple doses. The clinical results demonstrated a beneficial effect from supplementary lysine in accelerating recovery from [...]

Authors: Griffith RS, Wlash DE, Myrmel KH, Thompson RW PMID: 3115841 Abstract A double-blind, placebo-controlled, multicenter trial of oral L-lysine monohydrochloride for the prevention and treatment of recurrent herpes simplex (HSV) infection was conducted. The treatment group was given L-Lysine monohydrochloride tablets (1,000 mg L-lysine per dose) 3 times a day for 6 months. A [...]